Article Details
Retrieved on: 2025-01-12 21:42:39
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the epidemiology of systemic mastocytosis, highlighted by the launch and growth of the drug Avapritinib, enhancing treatment for this rare immune disorder. Tags like 'Kate Haviland' and 'tryptase' relate to Blueprint Medicines' efforts in targeting mast cell disorders.
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here